In the training set, compared with the control group, the NAFLD group showed significantly downregulated expression of ERN1, MYC, PPARGC1A, and SLC11A1, whereas TLR7 expression was significantly upregulated (Figure 5C). The gene discussed is TLR7; the disease is metabolic dysfunction-associated steatotic liver disease.